Literature DB >> 17118833

Acta Oncologica Lecture. Present status of the use of recombinant human TSH in thyroid cancer management.

Markus Luster1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17118833     DOI: 10.1080/02841860600979013

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  8 in total

1.  Cytogenetic and dosimetric effects of (131)I in patients with differentiated thyroid carcinoma: comparison between stimulation with rhTSH and thyroid hormone withdrawal treatments.

Authors:  Márcia Augusta da Silva; Flávia Gomes Silva Valgôde; Júlia Armiliato Gonzalez; Hélio Yoriyaz; Maria Inês Calil Cury Guimarães; Maria Teresa Carvalho Pinto Ribela; Carlos Alberto Buchpiguel; Paolo Bartolini; Kayo Okazaki
Journal:  Radiat Environ Biophys       Date:  2016-03-24       Impact factor: 1.925

2.  Guidelines for radioiodine therapy of differentiated thyroid cancer.

Authors:  M Luster; S E Clarke; M Dietlein; M Lassmann; P Lind; W J G Oyen; J Tennvall; E Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10       Impact factor: 9.236

3.  Evaluation of the cytogenetic effects of (131)I preceded by recombinant human thyrotropin (rhTSH) in peripheral lymphocytes of Wistar rats.

Authors:  Márcia Augusta da Silva; Maria Inês Calil Cury Guimarães; Hélio Yoriyaz; Maria Teresa Carvalho Pinto Ribela; Carlos Alberto Buchpiguel; Paolo Bartolini; Kayo Okazaki
Journal:  Radiat Environ Biophys       Date:  2008-08-19       Impact factor: 1.925

4.  Influence of a reduced CO2 environment on the secretion yield, potency and N-glycan structures of recombinant thyrotropin from CHO cells.

Authors:  João Ezequiel Oliveira; Renata Damiani; Karola Vorauer-Uhl; Paolo Bartolini; Maria Teresa C P Ribela
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

Review 5.  Blocking type TSH receptor antibodies.

Authors:  Jadwiga Furmaniak; Jane Sanders; Bernard Rees Smith
Journal:  Auto Immun Highlights       Date:  2012-03-21

Review 6.  Differentiated Thyroid Cancer-Treatment: State of the Art.

Authors:  Benedikt Schmidbauer; Karin Menhart; Dirk Hellwig; Jirka Grosse
Journal:  Int J Mol Sci       Date:  2017-06-17       Impact factor: 5.923

7.  N-Glycoprofiling Analysis for Carbohydrate Composition and Site-Occupancy Determination in a Poly-Glycosylated Protein: Human Thyrotropin of Different Origins.

Authors:  Maria Teresa C P Ribela; Renata Damiani; Felipe D Silva; Eliana R Lima; João E Oliveira; Cibele N Peroni; Peter A Torjesen; Carlos R Soares; Paolo Bartolini
Journal:  Int J Mol Sci       Date:  2017-02-03       Impact factor: 5.923

8.  Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal.

Authors:  Hsi-Chen Tsai; Kung-Chu Ho; Shih-Hsin Chen; Jing-Ren Tseng; Lan-Yan Yang; Kun-Ju Lin; Ju-Chin Cheng; Miaw-Jene Liou
Journal:  Diagnostics (Basel)       Date:  2022-01-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.